Retail Clinics Are a “Game-Changing” Threat

Five Reasons Why Retail Clinics Are a “Game-Changing” Threat to Traditional Healthcare Providers That Could Strain Clinical Laboratories and Pathologists Research conducted by Kalorama suggests the popularity of retail clinics represents a trend towards newer healthcare models that challenge existing models of care, and which could severely impact hospitals, clinical laboratories, and pathology groups In…

Medicare Price Cuts

Medicare Clinical Laboratory Price Cuts and Cost-cutting Predicted to be 2018’s Two Biggest Trends for Medical Laboratories in the United States To offset the loss of revenue from the price cuts to Medicare Part B clinical laboratory tests, labs will need to aggressively—but wisely—slash costs to balance their budgets Any day now, Medicare officials will…

Respiratory Pathogen Panel Test

It is crucial to determine quickly whether a patient is suffering from a bacterium or a virus, as the treatment protocols are quite different. For a doctor to treat the patient quickly and correctly, he/she needs to know precisely what the pathogen is…and Encore Holdings’ affiliated labs’ tests help with just that: They diagnose the…

Advanced Lipid Testing

Many physicians—not just internists, family practitioners, and gerontologists but even cardiologists—are unaware that fully 50 percent of patients with heart disease do not have the traditional risk markers. LDL-C and/or total cholesterol fail to project the full picture. They account for only 25 percent of the risk of premature cardiovascular disease. Did you know—and do…

The Latest in Tumor Testing

Encore Holdings’ affiliated labs offer tumor panels that take a deeper view of variation in solid tumors in many sites, including lung, colon, melanoma, gastric, and ovarian. Our assay targets 26 genes that are associated with these cancers and provides highly accurate variant analysis at limit of detection below 5% variant allele frequency across 174…

Genital Tract Infections – New PCR Test

The labs that Encore Holdings works with offer molecular testing for genital tract infections, with results provided the day after the sample is received. The physician can thus start treatments as much as one week faster than with culture- or antibody-based methods. The test identifies bacteria, fungi, protozoa, and mycoplasma, can detect bacteria even when…